Cargando…

Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico

The aim of this study was to determine the frequency of drug resistance and the clonality of genotype patterns in M. tuberculosis clinical isolates from pediatric patients in Mexico (n = 90 patients from 19 states; time period—January 2002 to December 2003). Pulmonary disease was the most frequent c...

Descripción completa

Detalles Bibliográficos
Autores principales: Macías Parra, Mercedes, Kumate Rodríguez, Jesús, Arredondo García, José Luís, López-Vidal, Yolanda, Castañón-Arreola, Mauricio, Balandrano, Susana, Rastogi, Nalin, Gutiérrez Castrellón, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335619/
https://www.ncbi.nlm.nih.gov/pubmed/22567263
http://dx.doi.org/10.1155/2011/239042
_version_ 1782230828934234112
author Macías Parra, Mercedes
Kumate Rodríguez, Jesús
Arredondo García, José Luís
López-Vidal, Yolanda
Castañón-Arreola, Mauricio
Balandrano, Susana
Rastogi, Nalin
Gutiérrez Castrellón, Pedro
author_facet Macías Parra, Mercedes
Kumate Rodríguez, Jesús
Arredondo García, José Luís
López-Vidal, Yolanda
Castañón-Arreola, Mauricio
Balandrano, Susana
Rastogi, Nalin
Gutiérrez Castrellón, Pedro
author_sort Macías Parra, Mercedes
collection PubMed
description The aim of this study was to determine the frequency of drug resistance and the clonality of genotype patterns in M. tuberculosis clinical isolates from pediatric patients in Mexico (n = 90 patients from 19 states; time period—January 2002 to December 2003). Pulmonary disease was the most frequent clinical manifestation (71%). Children with systemic tuberculosis (TB) were significantly younger compared to patients with localized TB infections (mean 7.7 ± 6.2 years versus 15 ± 3.4 years P = 0.001). Resistance to any anti-TB drug was detected in 24/90 (26.7%) of the isolates; 21/90 (23.3%) and 10/90 (11.1%) were resistant to Isoniazid and Rifampicin, respectively, and 10/90 (11.1%) strains were multidrug-resistant (MDR). Spoligotyping produced a total of 55 different patterns; 12/55 corresponded to clustered isolates (n = 47, clustering rate of 52.2%), and 43/55 to unclustered isolates (19 patterns were designated as orphan by the SITVIT2 database). Database comparison led to designation of 36 shared types (SITs); 32 SITs (n = 65 isolates) matched a preexisting shared type in SITVIT2, whereas 4 SITs (n = 6 isolates) were newly created. Lineage classification based on principal genetic groups (PGG) revealed that 10% of the strains belonged to PGG1 (Bovis and Manu lineages). Among PGG2/3 group, the most predominant clade was the Latin-American and Mediterranean (LAM) in 27.8% of isolates, followed by Haarlem and T lineages. The number of single drug-resistant (DR) and multidrug-resistant (MDR-TB) isolates in this study was similar to previously reported in studies from adult population with risk factors. No association between the spoligotype, age, region, or resistance pattern was observed. However, contrary to a study on M. tuberculosis spoligotyping in Acapulco city that characterized a single cluster of SIT19 corresponding to the EAI2-Manila lineage in 70 (26%) of patients, not a single SIT19 isolate was found in our pediatric patient population. Neither did we find any shared type belonging to the EAI family which represents ancestral PGG1 strains within the M. tuberculosis complex. We conclude that the population structure of pediatric TB in our setting is different from the one prevailing in adult TB patient population of Guerrero.
format Online
Article
Text
id pubmed-3335619
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33356192012-05-07 Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico Macías Parra, Mercedes Kumate Rodríguez, Jesús Arredondo García, José Luís López-Vidal, Yolanda Castañón-Arreola, Mauricio Balandrano, Susana Rastogi, Nalin Gutiérrez Castrellón, Pedro Tuberc Res Treat Research Article The aim of this study was to determine the frequency of drug resistance and the clonality of genotype patterns in M. tuberculosis clinical isolates from pediatric patients in Mexico (n = 90 patients from 19 states; time period—January 2002 to December 2003). Pulmonary disease was the most frequent clinical manifestation (71%). Children with systemic tuberculosis (TB) were significantly younger compared to patients with localized TB infections (mean 7.7 ± 6.2 years versus 15 ± 3.4 years P = 0.001). Resistance to any anti-TB drug was detected in 24/90 (26.7%) of the isolates; 21/90 (23.3%) and 10/90 (11.1%) were resistant to Isoniazid and Rifampicin, respectively, and 10/90 (11.1%) strains were multidrug-resistant (MDR). Spoligotyping produced a total of 55 different patterns; 12/55 corresponded to clustered isolates (n = 47, clustering rate of 52.2%), and 43/55 to unclustered isolates (19 patterns were designated as orphan by the SITVIT2 database). Database comparison led to designation of 36 shared types (SITs); 32 SITs (n = 65 isolates) matched a preexisting shared type in SITVIT2, whereas 4 SITs (n = 6 isolates) were newly created. Lineage classification based on principal genetic groups (PGG) revealed that 10% of the strains belonged to PGG1 (Bovis and Manu lineages). Among PGG2/3 group, the most predominant clade was the Latin-American and Mediterranean (LAM) in 27.8% of isolates, followed by Haarlem and T lineages. The number of single drug-resistant (DR) and multidrug-resistant (MDR-TB) isolates in this study was similar to previously reported in studies from adult population with risk factors. No association between the spoligotype, age, region, or resistance pattern was observed. However, contrary to a study on M. tuberculosis spoligotyping in Acapulco city that characterized a single cluster of SIT19 corresponding to the EAI2-Manila lineage in 70 (26%) of patients, not a single SIT19 isolate was found in our pediatric patient population. Neither did we find any shared type belonging to the EAI family which represents ancestral PGG1 strains within the M. tuberculosis complex. We conclude that the population structure of pediatric TB in our setting is different from the one prevailing in adult TB patient population of Guerrero. Hindawi Publishing Corporation 2011 2011-08-23 /pmc/articles/PMC3335619/ /pubmed/22567263 http://dx.doi.org/10.1155/2011/239042 Text en Copyright © 2011 Mercedes Macías Parra et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Macías Parra, Mercedes
Kumate Rodríguez, Jesús
Arredondo García, José Luís
López-Vidal, Yolanda
Castañón-Arreola, Mauricio
Balandrano, Susana
Rastogi, Nalin
Gutiérrez Castrellón, Pedro
Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico
title Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico
title_full Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico
title_fullStr Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico
title_full_unstemmed Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico
title_short Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico
title_sort mycobacterium tuberculosis complex genotype diversity and drug resistance profiles in a pediatric population in mexico
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335619/
https://www.ncbi.nlm.nih.gov/pubmed/22567263
http://dx.doi.org/10.1155/2011/239042
work_keys_str_mv AT maciasparramercedes mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT kumaterodriguezjesus mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT arredondogarciajoseluis mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT lopezvidalyolanda mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT castanonarreolamauricio mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT balandranosusana mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT rastoginalin mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico
AT gutierrezcastrellonpedro mycobacteriumtuberculosiscomplexgenotypediversityanddrugresistanceprofilesinapediatricpopulationinmexico